SEVERE FALCIPARUM MALARIA – PATHOPHYSIOLOGY, CLINICAL MANIFESTATIONS/ COMPLICATIONS, AND MANAGEMENT CHALLENGES IN NIGERIA
DOI:
https://doi.org/10.22159/ijms.2020.v8i1.35664Keywords:
Severe falciparum malaria, Pathophysiology and clinical manifestations of severe malaria, Nigeria, Management challenges of severe malariaAbstract
Severe falciparum malaria remains a common cause of death among the under-5 Nigerian children despite Nigerians having partial immunity arising from their residence in a hyperendemic region for malaria transmission. It is, also, being reported in clinical practice among adolescent and adult Nigerians. The objective of this narrative review is to highlight the pathophysiology of severe malaria and relate that to its clinical manifestations/ complications and to highlight the challenges of severe malaria management in Nigeria. With a good understanding of the pathophysiology of severe malaria as it relates to its clinical manifestations, one expects a favorable outcome from the current treatment protocol.
References
Snow RW, Omumbo JA. Malaria. In: Jamison DT, Feachem RG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, editors. Disease and Mortality in Sub-Saharan Africa. 2nd ed., Ch. 14. Washington, DC: The International Bank for Reconstruction and Development/ The World Bank; 2006.
World Health Organization. World Malarial Report 2018. Geneva: World Health Organization; 2018.
World Health Organization. Severe falciparum malaria, World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94 Suppl 1:S1-90.
Angyo IA, Pam SD, Sziachetka R. Clinical pattern and outcome in children with acute severe falciparum malaria at Jos University Teaching hospital, Nigeria. East Afr Med J 1996;73:823-6.
Edelu BO, Ndu IK, Igbokwe OO, Iloh ON. Severe falciparum Malaria in children in Enugu, South East, Nigeria. Niger J Clin Pract 2018;21:1349-55.
Bruneel F, Hocqueloux L, Alberti C, Wolff M, Chevret S, Bedos JP,et al. The Clinical spectrum of of severe imported falciparum malaria in the ICU: Report of 188 cases in adults. Am J Resp Crit Care Med 2003;167:684-9.
Blumberg L, Lee RP, Lipman J, Beards S. Predictors of mortality in severe malaria: A two year experience in a non-endemic area. Anaesth Intensive Care 1996;24:217-23.
Schwartz E, Sadetzki S, Murad H, Raveh D. Age as a risk factor for severe Plasmodium falciparum malaria in non-immune patients. Clin Infect Dis 2001;33:1774-7.
National Population Commission, National malaria Control Programme, ICF International. Nigeria Malaria Indicator Survey 2010 Abuja, Nigeria: NPC, NMCP, and ICF International; 2012.
White NJ, Breman JG. Malaria and babesiosis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. 18th ed., Vol. 323. New York: McGraw Hill; 2011. p. 1218-32.
Warrell DA, Looareesuwan S, Warrell MJ, Kasensarn P, Intaraprasert R, Dunnag D, et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982;306:313-9.
Gachot B, Wolff M, Nissack G, Veber G, Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest 1995;108:746-9.
Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review severe malaria. Crit Care 2003;7:315-23.
World Health Organization Guidelines for the Treatment of Malaria. 3rd ed., Ch. 7. Geneva: World Health Organization; 2015.
Published
How to Cite
Issue
Section
